Ticker LaunchUplisting · NTRB
NutriBand Inc.
NutriBand Inc. (NTRB), already reporting to the SEC, moved up to a national exchange on Oct 5, 2021 with an offering at $6.25 per share raising $6.6M. WallachBeth Capital was lead-left underwriter, joined by WestPark. Michael Paige Law and Carmel, Milazzo & Feil advised the underwriters.
NutriBand Inc. develops transdermal pharmaceutical products and provides contract research, development and manufacturing of transdermal, topical and coated products. Through its acquisition of 4P Therapeutics it plans to seek FDA approval for products, led by an abuse-deterrent fentanyl transdermal system for chronic pain.
- Status
- Uplisting
- Ticker
- NTRB
- Listed
- Oct 5, 2021
- Price
- $6.25
- Raised
- $6.6M
- Market cap at IPO price
- $46.3M
- First filed
- Jun 26, 2019
- Underwriters
- WallachBeth Capital and WestPark
- Underwriters' counsel
- Michael Paige Law and Carmel, Milazzo & Feil
- Sector
- Healthcare
- Country / state
- FL
More on this listing for subscribers
- Shares offered, over-allotment and shares outstanding after the offering
- Analyst notes on the filing
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration statement (S-1) first filed Jun 26, 2019
- Latest amendment Oct 1, 2021
- Final prospectus (424B4) Oct 5, 2021
- All filings on EDGAR CIK 1676047
Other Healthcare uplistings in 2021
- Nexgel, Inc.NXGL · Dec 27, 2021 · $14.2M
- BioRestorative Therapies, Inc.BRTXD · Nov 9, 2021 · $23M
- PetVivo Holdings, Inc.PETV · Aug 13, 2021 · $11.2M